Metropolitan Life Insurance CO Provention Bio, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.7 - $24.21 $502 - $1,815	-75 Reduced 2.09%	3,514 $84,000
Q4 2022 Jun 14, 2023	BUY	$4.52 - $10.57 $338 - $792	75 Added 2.13%	3,589 $37.9 Million
Q3 2022 Jun 14, 2023	BUY	$3.43 - $5.62 $257 - $421	75 Added 2.13%	3,589 $16.2 Million
Q3 2022 Mar 30, 2023	BUY	$3.43 - $5.62 $8,393 - $13,752	2,447 Added 214.27%	3,589 $16,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $8,393 - $13,752	2,447 Added 214.27%	3,589 $16,000
Q2 2022 Jun 20, 2023	SELL	$3.65 - $7.3 $8,657 - $17,315	-2,372 Reduced 67.5%	1,142 $4,000
Q2 2022 Mar 30, 2023	SELL	$3.65 - $7.3 $9,957 - $19,914	-2,728 Reduced 70.49%	1,142 $4,000
Q2 2022 Aug 11, 2022	SELL	$3.65 - $7.3 $9,957 - $19,914	-2,728 Reduced 70.49%	1,142 $5,000
Q1 2022 Jun 20, 2023	BUY	$3.4 - $7.88 $1,210 - $2,805	356 Added 10.13%	3,870 $28,000
Q1 2022 Mar 30, 2023	SELL	$3.4 - $7.88 $4,797 - $11,118	-1,411 Reduced 26.72%	3,870 $28,000
Q1 2022 May 12, 2022	SELL	$3.4 - $7.88 $4,797 - $11,118	-1,411 Reduced 26.72%	3,870 $28,000
Q4 2021 Jun 21, 2023	BUY	$5.59 - $7.39 $9,877 - $13,058	1,767 Added 50.28%	5,281 $29,000
Q4 2021 Mar 30, 2023	SELL	$5.59 - $7.39 $6,948 - $9,185	-1,243 Reduced 19.05%	5,281 $29,000
Q4 2021 Feb 15, 2022	SELL	$5.59 - $7.39 $6,948 - $9,185	-1,243 Reduced 19.05%	5,281 $30,000
Q3 2021 Jun 21, 2023	BUY	$5.66 - $8.33 $17,036 - $25,073	3,010 Added 85.66%	6,524 $41,000
Q3 2021 Mar 30, 2023	SELL	$5.66 - $8.33 $41,074 - $60,450	-7,257 Reduced 52.66%	6,524 $41,000
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $41,074 - $60,450	-7,257 Reduced 52.66%	6,524 $42,000
Q2 2021 Jun 21, 2023	BUY	$6.71 - $11.04 $68,891 - $113,347	10,267 Added 292.17%	13,781 $116,000
Q2 2021 Mar 30, 2023	BUY	$6.71 - $11.04 $10,232 - $16,836	1,525 Added 12.44%	13,781 $116,000
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $92,389 - $152,009	13,769 Added 114741.67%	13,781 $116,000
Q1 2021 Jun 26, 2023	BUY	$10.12 - $19.45 $88,469 - $170,031	8,742 Added 248.78%	12,256 $129 Million
Q1 2021 Mar 30, 2023	SELL	$10.12 - $19.45 $13,125 - $25,226	-1,297 Reduced 9.57%	12,256 $128,000
Q1 2021 May 14, 2021	SELL	$10.12 - $19.45 $137,034 - $263,372	-13,541 Reduced 99.91%	12 $129,000
Q4 2020 Jun 22, 2023	BUY	$11.79 - $18.94 $118,359 - $190,138	10,039 Added 285.69%	13,553 $229,000
Q3 2020 Jun 26, 2023	BUY	$10.34 - $15.2 $103,803 - $152,592	10,039 Added 285.69%	13,553 $173,000
Q2 2020 Jun 26, 2023	BUY	$7.81 - $17.0 $78,404 - $170,663	10,039 Added 285.69%	13,553 $191,000
Q2 2020 Mar 30, 2023	BUY	$7.81 - $17.0 $77,818 - $169,388	9,964 Added 277.63%	13,553 $191,000
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $105,848 - $230,401	13,553 New	13,553 $191,000

Others Institutions Holding PRVB

# of Institutions

Shares Held

170K

Call Options Held

Put Options Held

Odey Asset Management Group LTD London, X0

170K
Shares

$0
1.36% of portfolio

View Full List

About Provention Bio, Inc.

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

More about PRVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account